GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
MBX Biosciences $188 million IPO
The shares are listed on the Nasdaq Global Select Market
McKesson $2.49 billion acquisition of controlling interest in Core Ventures
We are advising McKesson on the transaction
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Tempus AI $410 million IPO
The stock is listed on the Nasdaq Global Select Market
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition